255 related articles for article (PubMed ID: 32964962)
1. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
He YC; Bi YG; Jiang L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
[TBL] [Abstract][Full Text] [Related]
2.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
3. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
8. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
Jin Y; Jiang A; Sun L; Lu Y
BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
[TBL] [Abstract][Full Text] [Related]
13. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
Chang H; Yao Y
Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
[TBL] [Abstract][Full Text] [Related]
17. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
Yang J; Liang B; Hou S
J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription.
Luo XJ; He MM; Liu J; Zheng JB; Wu QN; Chen YX; Meng Q; Luo KJ; Chen DL; Xu RH; Zeng ZL; Liu ZX; Luo HY
Exp Mol Med; 2022 Jun; 54(6):834-847. PubMed ID: 35760875
[TBL] [Abstract][Full Text] [Related]
20. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
Li Q; Wang S; Wu Z; Liu Y
Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
